[Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum]
- PMID: 19952520
- DOI: 10.1248/yakushi.129.1453
[Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum]
Abstract
Transdermal Drug Delivery Systems (TDDS), where active drugs must be absorbed into the systemic circulation after penetrating the skin barrier, were first launched in 1979, and about 10 TDDS containing different kinds of drugs were developed during the initial decade. Interestingly, a developmental rush has come again in the present century. Various penetration-enhancing approaches to improve drug permeation of the skin (stratum corneum) have been attempted. These approaches are of two types: chemical and physical. Examples of the chemical approach are enhancers such as alcohol, monoterpenes and fatty acid esters, as well as chemical modification of prodrugs. In contrast, physical approaches include the use of electrical-, thermal- and mechanical-energy, as well as microneedles, needle-free injectors or electroporation to completely or partially evade the barrier function in the stratum corneum. The chemical approaches are mainly effective in increasing the skin permeation of low-molecular chemicals, whereas physical means are effective for these chemicals but also high-molecules like peptides, proteins and nucleotides (DNA or RNA). Marked development has been observed in these physical means in the past decade. In addition, recent developments in tissue engineering technologies enables the use of cultured skin containing keratinocytes and fibroblasts as a TDDS. An effective "cell delivery system" may be a reality in the near future. This paper will look back on the 30-year history of TDDS and evaluate the feasibility of a new generation of these systems.
Similar articles
-
Approaches for breaking the barriers of drug permeation through transdermal drug delivery.J Control Release. 2012 Nov 28;164(1):26-40. doi: 10.1016/j.jconrel.2012.09.017. Epub 2012 Oct 10. J Control Release. 2012. PMID: 23064010 Review.
-
Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.Curr Med Chem. 2000 Jun;7(6):593-608. doi: 10.2174/0929867003374840. Curr Med Chem. 2000. PMID: 10702628 Review.
-
Recent advances in transdermal drug delivery.Arch Pharm Res. 2010 Mar;33(3):339-51. doi: 10.1007/s12272-010-0301-7. Epub 2010 Mar 30. Arch Pharm Res. 2010. PMID: 20361297 Review.
-
[Transdermal Drug Delivery Systems: From the Dawn and Early Stage to the Development and Maturity Stage, and the Future].Yakugaku Zasshi. 2022;142(11):1227-1253. doi: 10.1248/yakushi.22-00113. Yakugaku Zasshi. 2022. PMID: 36328451 Review. Japanese.
-
Overcoming skin barriers through advanced transdermal drug delivery approaches.J Control Release. 2022 Nov;351:361-380. doi: 10.1016/j.jconrel.2022.09.025. Epub 2022 Sep 24. J Control Release. 2022. PMID: 36169040 Review.
Cited by
-
Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants.Mol Pharm. 2012 Jul 2;9(7):2111-20. doi: 10.1021/mp300146m. Epub 2012 Jun 15. Mol Pharm. 2012. PMID: 22702370 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous